PARIS (Reuters) – Russia-born billionaire and Telegram owner Pavel Durov was still being detained for questioning by French police on Monday, local news channel franceinfo reported, after he was arrested and taken into custody at the weekend. “The police custody is continuing on Monday, …and may last up to four days”, the report said. The …
Telegram’s Durov still held by French police, franceinfo reports Read More »
ZURICH (Reuters) -Swiss solar panel maker Meyer Burger said on Monday it was suspending plans for a plant in Colorado as it announced restructuring measures and suggested profitability would be lower than previously expected. “Meyer Burger Technology AG announced today that the planned construction of a solar cell production facility in Colorado Springs, Colorado, USA, …
Meyer Burger halts solar plant in Colorado, plans restructuring Read More »
By Ingrid Melander and Guy Faulconbridge PARIS/MOSCOW (Reuters) -Pavel Durov, the Russian-born billionaire founder and owner of the Telegram messaging app, was arrested at Le Bourget airport outside Paris shortly after landing on a private jet late on Saturday and placed in custody, three sources told Reuters. The arrest of the 39-year-old technology billionaire prompted …
Telegram founder Durov arrested in France, sources says Read More »
(Widens distribution.) ZURICH (Reuters) -Nestle intends to keep its Health Science unit, Chairman Paul Bulcke said in a newspaper interview published on Sunday, after the food giant announced it was replacing its CEO Mark Schneider with company veteran Laurent Freixe. The health business is among the Nestle units which some analysts say could be sold …
Nestle to keep Health Science unit after CEO’s exit, chairman tells paper Read More »
By Ebru Tuncay ISTANBUL (Reuters) – Turkish banks will pay the price throughout next year as challenges linger from the country’s economic turnaround, the chief executive of lender Isbank said in an interview, adding he expects the central bank to begin cutting interest rates this November. CEO Hakan Aran told Reuters that Turkey’s largest private …
Turkey’s Isbank CEO sees challenges ahead, November rate cut Read More »
By Elizabeth Piper LONDON (Reuters) – Prime Minister Keir Starmer will warn Britons next week that the changes needed to fix Britain’s many problems will take time, saying “things will get worse before we get better” in a speech he describes as a chance to level with the public. After being elected as prime minister …
‘Things will get worse’ – PM Starmer says fixing UK problems will take time Read More »
JACKSON HOLE, Wyoming (Reuters) -The European Central Bank is making “good progress” in cutting inflation back to its 2% target but success is not yet assured, so restrictive monetary policy is still needed, ECB chief economist Philip Lane said on Saturday. The ECB cut interest rates for the first time in June after a record …
ECB making good progress but job not done, Lane says Read More »
(Reuters) -Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans. The German health technology company will pay more than 200 million euros ($224 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned …
Novartis receives binding offer from Siemens Healthineers for molecular imaging business Read More »
ZURICH (Reuters) – Debt levels in the United States and Europe are a risk for international financial stability and for Switzerland, Swiss Finance Minister Karin Keller-Sutter said in a newspaper interview published on Saturday. In an interview with Swiss daily Blick, Keller-Sutter extolled Switzerland’s “disciplined” finances, which she said had enabled the country to deal …
Swiss finance minister chides US, Europe over ‘time bomb’ debt levels Read More »
(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS), the Telegraph reported on Friday. The drug donanemab would be rejected by the National Institute for Health and Care Excellence (NICE), which decides what drugs are available on the NHS, the newspaper reported citing insiders. …
Eli Lilly Alzheimer’s drug to be blocked for use by NHS, The Telegraph reports Read More »
